SCHEMBL1208128

SCHEMBL1208128

CCNC(=O)OCC1CCc2c(sc(NC(=O)C=Cc3cccnc3)c2C#N)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.52
ALDH1A1 P00352 8/20 0.48
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
TGFBR1 P36897 1/20 0.44
MAPT P10636 6/20 0.42
POLB P06746 4/20 0.42
HPGD P15428 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 1/20 0.42
KDM4E B2RXH2 3/20 0.41
NAMPT P43490 2/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
NR0B1 P51843 1/20 0.40
SAE1 Q9UBE0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12883776 1.00 PTPN5 (0.52) PTPN5ALDH1A1RAB9ANPC1ALOX15
SCHEMBL12882526 1.00 PTPN5 (0.52) PTPN5ALDH1A1RAB9ANPC1ALOX15
SCHEMBL12895497 0.94 PTPN5 (0.51) PTPN5ALDH1A1RAB9ANPC1ALOX15
SCHEMBL1207119 0.94 PTPN5 (0.51) PTPN5ALDH1A1RAB9ANPC1ALOX15
SCHEMBL1207628 0.93 PTPN5 (0.48) PTPN5ALDH1A1RAB9ANPC1ALOX15
SCHEMBL12895449 0.93 PTPN5 (0.48) PTPN5ALDH1A1RAB9ANPC1ALOX15
SCHEMBL12882543 0.92 PTPN5 (0.51) PTPN5ALDH1A1RAB9ANPC1ALOX15
SCHEMBL12883784 0.92 PTPN5 (0.51) PTPN5ALDH1A1RAB9ANPC1ALOX15
SCHEMBL1208155 0.92 PTPN5 (0.51) PTPN5ALDH1A1RAB9ANPC1ALOX15
SCHEMBL12895697 0.92 PTPN5 (0.51) PTPN5ALDH1A1RAB9ANPC1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US claimed
EP-2051974-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2009-04-29 EP claimed
WO-2008020045-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2008-02-21 WO claimed
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US disclosed
EP-2051974-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2009-04-29 EP disclosed
WO-2008020045-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES BAX, BCL2, BAD PTPN5 1174/4885ALDH1A1 316/4885RAB9A 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.